SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-16-008212
Filing Date
2016-03-23
Accepted
2016-03-23 16:04:58
Documents
95
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1325926
2 image_001.jpg GRAPHIC 8124
3 ex10-30.htm EX-10.30 58893
4 ex21-1.htm EX-21.1 4805
5 ex23-1.htm EX-23.1 2350
6 ex31-1.htm EX-31.1 17687
7 ex31-2.htm EX-31.2 18301
8 ex32-1.htm EX-32.1 7231
9 ex32-2.htm EX-32.2 6892
  Complete submission text file 0001493152-16-008212.txt   6815440

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE immy-20151231.xml EX-101.INS 1055834
11 XBRL SCHEMA FILE immy-20151231.xsd EX-101.SCH 81135
12 XBRL CALCULATION FILE immy-20151231_cal.xml EX-101.CAL 110967
13 XBRL DEFINITION FILE immy-20151231_def.xml EX-101.DEF 313971
14 XBRL LABEL FILE immy-20151231_lab.xml EX-101.LAB 622617
15 XBRL PRESENTATION FILE immy-20151231_pre.xml EX-101.PRE 452792
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35814 | Film No.: 161523964
SIC: 2834 Pharmaceutical Preparations